Higher COVID-19 hospitalization and mortality rates in MS patients despite vaccination

New real-world research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) reveals that people living with multiple sclerosis (MS) face a much higher risk of being hospitalised and dying from COVID-19 than the general population.

Acreage Q1 Revenue Slips

Acreage Reports First Quarter 2023 Financial Results Achieved Ninth Consecutive Quarter of Positive Adjusted EBITDA Received Shareholder Approval for Strategic Arrangement with Canopy and Canopy

Read More »